SHOULD WE ABANDON METRONIDAZOLE CONTAINING HELICOBACTER PYLORI TREATMENT REGIMENS? THE CLINICAL RELEVANCE OF METRONIDAZOLE RESISTANCE
- 1 January 1998
- journal article
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 93 (1) , 2-3
- https://doi.org/10.1111/j.1572-0241.1998.002_c.x
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Adding once-daily omperazole 20 mg to metronidazole/amoxicillin treatment for Helicobacter pylori gastritis: a randomized, double-blind trial showing the importance of metronidazole resistanceAmerican Journal of Gastroenterology, 1998
- Successful low-dose amoxycillin, metronidazole and omeprazole combination therapy in a population with a high frequency of metronidazole-resistant Helicobacter pyloriAlimentary Pharmacology & Therapeutics, 1997
- One‐week triple therapy with omeprazole, amoxycillin and tinidazole for Helicobacter pylori infection: the significance of imidazole resistanceAlimentary Pharmacology & Therapeutics, 1997
- Resistance of Helicobacter pylori to antibioticsAlimentary Pharmacology & Therapeutics, 1997
- Oxygen scavenging, NADH oxidase and metronidazole resistance in Helicobacter pyloriJournal of Antimicrobial Chemotherapy, 1997
- Randomized comparison of differing periods of twice‐a‐day triple therapy for the eradication of Helicobacter pyloriAlimentary Pharmacology & Therapeutics, 1996
- Metronidazole resistance: A predictor of failure of Helicobacter pylori eradication by triple therapyJournal of Gastroenterology and Hepatology, 1996
- Impact of Metronidazole Resistance on the Eradication of Helicobacter pyloriScandinavian Journal of Infectious Diseases, 1994